Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.25NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BF.25NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.5.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.9NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BA.5.9NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BF.7.4.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BF.7.4.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4625.82China
BF.7.4.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BN.1.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BN.1.3.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BN.1.3.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BL.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BL.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.5.2.47ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.5.2.47NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BA.5.2.47NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
ED.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
ED.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
ED.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
BN.1.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BN.1.2.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BN.1.2.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
CQ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
CQ.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
CQ.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
CH.1.1.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
CH.1.1.24NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
CH.1.1.24NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.5.2.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.43NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BA.5.2.43NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.5.2.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.19NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BA.5.2.19NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BF.38.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.38.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BF.38.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BF.7.19.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.19.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BF.7.19.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BQ.1.1.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.43NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4625.82China
BQ.1.1.43NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
BA.5.2.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.12NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BA.5.2.12NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BF.7.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.23NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
BF.7.23NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used